Iambic Therapeutics
Founded Year
2019Stage
Series B - II | AliveTotal Raised
$206.23MLast Raised
$50M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-13 points in the past 30 days
About Iambic Therapeutics
Iambic Therapeutics focuses on drug discovery using an AI (artificial intelligence)-driven platform within the pharmaceutical industry. The company specializes in designing optimized medicines by using physics-based AI algorithms to explore chemical space and develop novel mechanisms of action. It primarily serves the healthcare sector by targeting unmet patient needs with its pipeline of therapeutic programs. Iambic Therapeutics was formerly known as Entos. It was founded in 2019 and is based in San Diego, California.
Loading...
Loading...
Research containing Iambic Therapeutics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Iambic Therapeutics in 6 CB Insights research briefs, most recently on May 23, 2025.
May 23, 2025
The AI in drug R&D market map
Dec 3, 2024 report
Digital Health 50: The most promising digital health startups of 2024
Jul 2, 2024 team_blog
How to buy AI: Assessing AI startups’ potential
Expert Collections containing Iambic Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Iambic Therapeutics is included in 7 Expert Collections, including Digital Health.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Drug Discovery Tech Market Map
221 items
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
AI 100 (2024)
100 items
Artificial Intelligence
10,047 items
Digital Health 50
50 items
AI in drug discovery
521 items
Companies using AI to advance therapeutic discovery, categorized into: platforms (primary product is software) and discovery engines (primary product is therapeutics). Additional funnel descriptions reflect how companies are applying AI.
Iambic Therapeutics Patents
Iambic Therapeutics has filed 7 patents.
The 3 most popular patent topics include:
- building engineering
- cell biology
- cell cycle
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/24/2020 | 3/25/2025 | Ventilation, Engine technology, Energy recovery, Building engineering, Sustainable building | Grant |
Application Date | 1/24/2020 |
|---|---|
Grant Date | 3/25/2025 |
Title | |
Related Topics | Ventilation, Engine technology, Energy recovery, Building engineering, Sustainable building |
Status | Grant |
Latest Iambic Therapeutics News
Jun 26, 2025
SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the GPU cloud company founded by AI engineers, today announced that Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, has selected Lambda to provide an NVIDIA HGX B200 cluster to support the training of Enchant, its industry-leading model for molecular property prediction. Iambic’s Enchant is a breakthrough multi-modal transformer model for predic
Iambic Therapeutics Frequently Asked Questions (FAQ)
When was Iambic Therapeutics founded?
Iambic Therapeutics was founded in 2019.
Where is Iambic Therapeutics's headquarters?
Iambic Therapeutics's headquarters is located at 5627 Oberlin Drive, San Diego.
What is Iambic Therapeutics's latest funding round?
Iambic Therapeutics's latest funding round is Series B - II.
How much did Iambic Therapeutics raise?
Iambic Therapeutics raised a total of $206.23M.
Who are the investors of Iambic Therapeutics?
Investors of Iambic Therapeutics include Coatue, Illumina Ventures, Abingworth, Mubadala Capital, Qatar Investment Authority and 15 more.
Who are Iambic Therapeutics's competitors?
Competitors of Iambic Therapeutics include Algorithmic Biologics.
Loading...
Compare Iambic Therapeutics to Competitors
Algorithmic Biologics provides molecular computing solutions for diagnostics and research in the life sciences industry. The company offers cloud-delivered services that improve the processes of PCR, NGS, mass spectrometry, assay design, and drug discovery. Algorithmic Biologics serves sectors that require molecular analysis and diagnostics, including healthcare and pharmaceutical research. It was founded in 2021 and is based in Bengaluru, India.
10X Genomics focuses on genomic and spatial analysis technologies in the biotechnology sector. It provides products for researchers to conduct single-cell sequencing and spatial transcriptomics, enabling the study of cellular diversity and gene expression. Its tools are used in oncology, immunology, and neuroscience. It was founded in 2012 and is based in Pleasanton, California.
Oxford Nanopore Technologies specializes in deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing technology within the biotechnology sector. The company offers products and solutions for DNA and RNA sequencing, including library preparation, sequencing devices, flow cells, and data analysis tools. Its products enable the analysis of genetic material for research in areas such as microbiology, human genetics, cancer, and environmental studies. Oxford Nanopore Technologies was formerly known as Oxford NanoLabs. It was founded in 2005 and is based in Oxford, United Kingdom.
Loading...